MIQ 001Alternative Names: MIQ-001
Latest Information Update: 30 Mar 2016
At a glance
- Originator Meta-IQ
- Class Small molecules
- Mechanism of Action Carnitine O-palmitoyltransferase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Multiple sclerosis; Optic neuritis
Most Recent Events
- 30 Mar 2016 Phase-I clinical trials in Optic neuritis in Denmark (unspecified route)
- 30 Mar 2016 Phase-I clinical trials in Multiple sclerosis in Denmark (unspecified route)